tirzepatide in the news Wow! It really shows demand for these weight loss drugs... https://www.bbc.co.uk/news/articles/czdr3zl98e4o Weight-loss jab Mounjaro trial begins

Lower Medication Dependency: Those on GLP-1 drugs were 13% less likely to need triptans (for stopping attacks) and significantly less likely to start new preventive meds like CGRP antibodies (42% reduction) or gepants (23% reduction)

You can delay the signs of aging and avoid more invasive treatments down the line

It is influenced by appetite signaling, insulin resistance, genetics, fat distribution, hormones, sleep quality, inflammation, medications, stress, muscle mass, thyroid function, aging, and the bodys natural tendency to defend weight

Injections deliver significantly higher absorption and better results

Side effects at 1.0mg (20 units) Nausea incidence rises to about 20 percent at this dose